Study Casts Doubt on Cytomegalovirus Prevention Strategy Medscape DENVER — The new standard of care, valganciclovir, is inferior to established combination therapy in patients undergoing high-risk orthotopic liver transplantation, a new study suggests. In the pivotal clinical trials on which US Food and Drug ... |
